Finance

Lists
301333:SHE
R&G PharmaStudies Co Ltd
CNÂ¥51.59
-1.40%
(-0.73) 1D
Nov 17, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301333...
Open
CNÂ¥52.10
High
CNÂ¥53.35
Low
CNÂ¥51.07
Mkt. cap
5.05B
Avg. vol.
2.30M
Volume
1.03M
Dividend
0.31%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 3, 2026
P/E ratio
42.20
52-wk high
CNÂ¥91.78
52-wk low
CNÂ¥43.79
EPS
CNÂ¥1.22
Shares outstanding
96.58M
No. of employees
3K
Open
CNÂ¥52.10
High
CNÂ¥53.35
Low
CNÂ¥51.07
Mkt. cap
5.05B
Avg. vol.
2.30M
Volume
1.03M
Dividend
0.31%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 3, 2026
P/E ratio
42.20
52-wk high
CNÂ¥91.78
52-wk low
CNÂ¥43.79
EPS
CNÂ¥1.22
Shares outstanding
96.58M
No. of employees
3K
News stories
From web sources and news partners
About R&G PharmaStudies Co Ltd
CEO-
Employees2.64K
FoundedAug 22, 2008
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
243.64M
218.09M
249.87M
245.83M
Cost of goods sold
164.25M
152.25M
174.53M
174.40M
Cost of revenue
164.25M
152.25M
174.53M
174.40M
Research and development expenses
16.19M
15.51M
18.39M
19.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.78M
23.05M
24.60M
24.72M
Operating expense
50.32M
39.67M
50.25M
42.97M
Total operating expenses
214.57M
191.92M
224.78M
217.37M
Operating income
29.07M
26.18M
25.09M
28.46M
Other non operating income
1.43M
-3.03M
3.02M
-8.29M
EBT including unusual items
45.33M
25.76M
24.43M
32.76M
EBT excluding unusual items
32.65M
26.20M
22.97M
31.34M
Income tax expense
3.87M
2.88M
1.95M
498.44K
Effective tax rate
8.54%
11.16%
7.97%
1.52%
Other operating expenses
1.05M
1.01M
1.30M
1.15M
Net income
41.33M
22.83M
21.64M
30.72M
Net profit margin
16.96%
10.47%
8.66%
12.50%
Earnings per share
-
-
-
-
Interest and investment income
6.24M
3.65M
1.47M
5.54M
Interest expense
-623.36K
-605.42K
-567.67K
-415.22K
Net interest expenses
5.62M
3.05M
906.53K
5.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
30.77M
27.88M
26.74M
30.16M
Gain or loss from assets sale
9.34K
-
-3.52K
3.52K
Upcoming events
AI content may include mistakes. Learn more
Google apps